These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 20825487

  • 1. Changes in arterial stiffness during continued infliximab treatment in patients with inflammatory arthropathies.
    Angel K, Provan SA, Hammer HB, Mowinckel P, Kvien TK, Atar D.
    Fundam Clin Pharmacol; 2011 Aug; 25(4):511-7. PubMed ID: 20825487
    [Abstract] [Full Text] [Related]

  • 2. Non-invasive assessment of arterial stiffness indices by applanation tonometry and pulse wave analysis in patients with rheumatoid arthritis treated with TNF-alpha blocker remicade (infliximab).
    Cypiene A, Laucevicius A, Venalis A, Ryliskyte L, Dadoniene J, Petrulioniene Z, Kovaite M, Laskova V, Gintautas J.
    Proc West Pharmacol Soc; 2007 Aug; 50():119-22. PubMed ID: 18605247
    [Abstract] [Full Text] [Related]

  • 3. Tumor necrosis factor-alpha antagonists improve aortic stiffness in patients with inflammatory arthropathies: a controlled study.
    Angel K, Provan SA, Gulseth HL, Mowinckel P, Kvien TK, Atar D.
    Hypertension; 2010 Feb; 55(2):333-8. PubMed ID: 20038753
    [Abstract] [Full Text] [Related]

  • 4. Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab.
    Spanakis E, Sidiropoulos P, Papadakis J, Ganotakis E, Katsikas G, Karvounaris S, Bizaki A, Kritikos H, Boumpas DT.
    J Rheumatol; 2006 Dec; 33(12):2440-6. PubMed ID: 17014005
    [Abstract] [Full Text] [Related]

  • 5. Infliximab is associated with improvement in arterial stiffness in patients with early rheumatoid arthritis -- a randomized trial.
    Tam LS, Shang Q, Li EK, Wang S, Li RJ, Lee KL, Leung YY, Ying KY, Yim CW, Kun EW, Leung MH, Li M, Li TK, Zhu TY, Chui RK, Tseung L, Yu SL, Kuan WP, Yu CM.
    J Rheumatol; 2012 Dec; 39(12):2267-75. PubMed ID: 22984272
    [Abstract] [Full Text] [Related]

  • 6. No significant changes in arterial stiffness in patients with ankylosing spondylitis after tumour necrosis factor alpha blockade treatment for 6 and 12 months.
    Mathieu S, Pereira B, Couderc M, Rabois E, Dubost JJ, Soubrier M.
    Rheumatology (Oxford); 2013 Jan; 52(1):204-9. PubMed ID: 23065359
    [Abstract] [Full Text] [Related]

  • 7. Predictors of infusion reactions during infliximab treatment in patients with arthritis.
    Kapetanovic MC, Larsson L, Truedsson L, Sturfelt G, Saxne T, Geborek P.
    Arthritis Res Ther; 2006 Jan; 8(4):R131. PubMed ID: 16869978
    [Abstract] [Full Text] [Related]

  • 8. Effect of 1-year anti-TNF-α therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study.
    Angel K, Provan SA, Fagerhol MK, Mowinckel P, Kvien TK, Atar D.
    Am J Hypertens; 2012 Jun; 25(6):644-50. PubMed ID: 22378036
    [Abstract] [Full Text] [Related]

  • 9. Infliximab improves vascular stiffness in patients with rheumatoid arthritis.
    Wong M, Oakley SP, Young L, Jiang BY, Wierzbicki A, Panayi G, Chowienczyk P, Kirkham B.
    Ann Rheum Dis; 2009 Aug; 68(8):1277-84. PubMed ID: 18930987
    [Abstract] [Full Text] [Related]

  • 10. Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritis.
    Van Doornum S, McColl G, Wicks IP.
    Rheumatology (Oxford); 2005 Nov; 44(11):1428-32. PubMed ID: 16076882
    [Abstract] [Full Text] [Related]

  • 11. The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis.
    Elkayam O, Bashkin A, Mandelboim M, Litinsky I, Comaheshter D, Levartovsky D, Mendelson E, Wigler I, Caspi D, Paran D.
    Semin Arthritis Rheum; 2010 Jun; 39(6):442-7. PubMed ID: 19246078
    [Abstract] [Full Text] [Related]

  • 12. Time-course of health status in patients with rheumatoid arthritis during the first year of treatment with infliximab.
    Ban A, Inaba M, Furumitsu Y, Okamoto K, Yukioka K, Goto H, Nishizawa Y.
    Biomed Pharmacother; 2010 Feb; 64(2):107-12. PubMed ID: 19944558
    [Abstract] [Full Text] [Related]

  • 13. Serum soluble receptor for advanced glycation end products levels and aortic augmentation index in early rheumatoid arthritis--a prospective study.
    Tam LS, Shang Q, Li EK, Wong S, Li RJ, Lee KL, Leung YY, Ying KY, Yim CW, Kun EW, Leung MH, Li M, Li TK, Zhu TY, Chui RK, Tseung L, Yu SL, Kuan WP, Yu CM.
    Semin Arthritis Rheum; 2013 Feb; 42(4):333-45. PubMed ID: 22920235
    [Abstract] [Full Text] [Related]

  • 14. Persistent clinical response to the anti-TNF-alpha antibody infliximab in patients with ankylosing spondylitis over 3 years.
    Braun J, Baraliakos X, Brandt J, Listing J, Zink A, Alten R, Burmester G, Gromnica-Ihle E, Kellner H, Schneider M, Sörensen H, Zeidler H, Sieper J.
    Rheumatology (Oxford); 2005 May; 44(5):670-6. PubMed ID: 15757965
    [Abstract] [Full Text] [Related]

  • 15. The effect of infliximab on oxidative stress in chronic inflammatory joint disease.
    Túnez I, Feijóo M, Huerta G, Montilla P, Muñoz E, Ruíz A, Collantes E.
    Curr Med Res Opin; 2007 Jun; 23(6):1259-67. PubMed ID: 17559725
    [Abstract] [Full Text] [Related]

  • 16. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).
    Antoni CE, Kavanaugh A, Kirkham B, Tutuncu Z, Burmester GR, Schneider U, Furst DE, Molitor J, Keystone E, Gladman D, Manger B, Wassenberg S, Weier R, Wallace DJ, Weisman MH, Kalden JR, Smolen J.
    Arthritis Rheum; 2005 Apr; 52(4):1227-36. PubMed ID: 15818699
    [Abstract] [Full Text] [Related]

  • 17. Increased arterial stiffness and indication of endothelial dysfunction in long-standing rheumatoid arthritis.
    Wållberg-Jonsson S, Caidahl K, Klintland N, Nyberg G, Rantapää-Dahlqvist S.
    Scand J Rheumatol; 2008 Apr; 37(1):1-5. PubMed ID: 18189187
    [Abstract] [Full Text] [Related]

  • 18. The L-arginine/asymmetric dimethylarginine ratio is improved by anti-tumor necrosis factor-α therapy in inflammatory arthropathies. Associations with aortic stiffness.
    Angel K, Provan SA, Mowinckel P, Seljeflot I, Kvien TK, Atar D.
    Atherosclerosis; 2012 Nov; 225(1):160-5. PubMed ID: 23014354
    [Abstract] [Full Text] [Related]

  • 19. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy.
    Mäki-Petäjä KM, Hall FC, Booth AD, Wallace SM, Yasmin, Bearcroft PW, Harish S, Furlong A, McEniery CM, Brown J, Wilkinson IB.
    Circulation; 2006 Sep 12; 114(11):1185-92. PubMed ID: 16952987
    [Abstract] [Full Text] [Related]

  • 20. Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis.
    Kiortsis DN, Mavridis AK, Filippatos TD, Vasakos S, Nikas SN, Drosos AA.
    J Rheumatol; 2006 May 12; 33(5):921-3. PubMed ID: 16541480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.